未找到相关数据
The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
被引：0
作者：
Si, X.
[1
]
Zhang, L.
[2
]
Wang, H.
[1
]
Zhang, X.
[2
]
Wang, M.
[1
]
Han, B.
[3
]
Li, K.
[4
]
Wang, Q.
[5
]
Shi, J.
[6
]
Wang, Z.
[7
]
Cheng, Y.
[8
]
He, J.
[9
]
Shi, Y.
[10
,11
]
Chen, W.
[12
]
Wang, X.
[13
]
Luo, Y.
[14
]
Nan, K.
[15
]
Jin, F.
[16
]
Li, B.
[17
]
Chen, Y.
[18
]
Zhou, J.
[19
]
Wang, D.
[20
]
机构：
[1] Beijing Union Med Coll Hosp, Resp Med, Beijing, Peoples R China
[2] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[3] Shanghai Chest Hosp, Shanghai, Peoples R China
[4] Tianjin Med Univ, Canc Hosp, Tianjin, Peoples R China
[5] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Internal Med, Zhengzhou, Henan, Peoples R China
[6] Linyi City Tumor Hosp, Linyi, Peoples R China
[7] Shandong Prov Tumor Hosp, Jinan, Shandong, Peoples R China
[8] Jilin Prov Canc Hosp, Thorac Oncol, Changchun, Jilin, Peoples R China
[9] Guangzhou Med Univ, Affiliated Hosp 1, Thorac Surg, Guangzhou, Guangdong, Peoples R China
[10] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China
[11] Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China
[12] Lanzhou Mil Gen Hosp, Lanzhou, Gansu, Peoples R China
[13] Qilu Hosp, Jinan, Shandong, Peoples R China
[14] Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China
[15] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
[16] Tangdu Hosp, Xian, Shaanxi, Peoples R China
[17] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China
[18] Jiangxi Prov Tumor Hosp, Nanchang, Jiangxi, Peoples R China
[19] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
[20] Chongqing Canc Hosp, Chongqing, Peoples R China
关键词：
Anlotinib;
non-small cell lung cancer;
quality of life;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-107
引用
收藏
页码：S505 / S505
页数：1
相关论文